ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,607Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 546

$1.75M Total Retail Price of All Prescriptions

Rank: 1 out of 546

248 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

27% of this provider’s 248 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

25% of this provider’s 248 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 3,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$265 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
TRUVADA 217 0 1 168
SERTRALINE HCL 181 166 2 14
LEVOTHYROXINE SODIUM 176 136 3 3
OXYCODONE HCL 162 17 S2 4 15
FUROSEMIDE 153 129 5 5
LISINOPRIL 138 105 6 1
DONEPEZIL HCL 138 138 6 31
HYDROCODONE-ACETAMINOPHEN 124 63 S3 8 8
OXYCONTIN 121 13 S2 9 75
MIRTAZAPINE 119 111 10 51
NORVIR 111 16 11 201
OMEPRAZOLE 105 68 12 4
POTASSIUM CHLORIDE 105 101 12 30
TRAZODONE HCL 88 36 14 25
SIMVASTATIN 83 78 15 2
HYDROCHLOROTHIAZIDE 71 41 16 7
DRONABINOL 69 0 17 220
ATENOLOL 69 65 17 12
ZOLPIDEM TARTRATE 69 0 17 26
PANTOPRAZOLE SODIUM 68 47 20 18
CITALOPRAM HBR 67 48 21 21
PREZISTA 66 13 22 223
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 46 23 104
POLYETHYLENE GLYCOL 3350 63 62 24 68
AMLODIPINE BESYLATE 60 48 25 9
AZITHROMYCIN 60 27 25 55
GABAPENTIN 57 0 27 16
METOPROLOL TARTRATE 57 54 27 6
WARFARIN SODIUM 57 36 27 13
NAMENDA 56 56 30 60
CYMBALTA 54 0 31 37
METOPROLOL SUCCINATE 54 19 31 17
RISPERIDONE 51 40 33 47
IBUPROFEN 51 0 33 70
PAROXETINE HCL 50 38 35 43
CYCLOBENZAPRINE HCL 50 0 R 35 34
BUTRANS 50 0 S3 35 246
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.